Implications of the FDA approval of PCSK9 Inhibitors and FOURIER Results for Contemporary Cardiovascular Practice: An NCDR® Research to Practice (R2P) Project
Hess, Paul L., Kennedy, Kevin, Cowherd, Michael, Virani, Salim S., Masoudi, Frederick A., Navar, Ann Marie, Yeh, Robert W., Ho, P. Michael, Maddox, Thomas M.Мова:
english
Журнал:
American Heart Journal
DOI:
10.1016/j.ahj.2017.09.004
Date:
September, 2017
Файл:
PDF, 443 KB
english, 2017
File converter
Більше результатів пошуку
More benefits 
